LP-003 Significantly Decreases Chronic Spontaneous Urticaria Disease Activity and is Well Tolerated: Top Line Results from a Phase 2 Trial

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Feng Hu, Liming Wu, Cuicui Han, Jie Yang, Heng Liu, Rongfei Zhu, Yuxiang Zhi, Xinghua Gao

DOI: 10.1016/j.jaci.2025.12.941

Cited by: 0

Fields of Study & Subjects

Urticaria and Related Conditions Mast cells and histamine Dermatology and Skin Diseases